Search Results - "Palatka, K"

Subjective expectations regarding longevity and future health: a cross‐sectional survey among patients with Crohn's disease by Péntek, M., Gulácsi, L., Herszényi, L., Banai, J., Palatka, K., Lakatos, P. L., Brodszky, V., Rencz, F.

“…Aim The aim was to explore the subjective health expectations (sHE) of patients with Crohn's disease (CD) for both the near future and the elderly. Method A…”
Get full text

Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn’s disease by Kiss, L. S., Szamosi, T., Molnar, T., Miheller, P., Lakatos, L., Vincze, A., Palatka, K., Barta, Z., Gasztonyi, B., Salamon, A., Horvath, G., Tóth, G. T., Farkas, K., Banai, J., Tulassay, Z., Nagy, F., Szenes, M., Veres, G., Lovasz, B. D., Vegh, Z., Golovics, P. A., Szathmari, M., Papp, M., Lakatos, P. L.

“…Aliment Pharmacol Ther 2011; 34: 911–922 Summary Background  Adalimumab is a fully human monoclonal antibody targeting tumour necrosis factor with proven…”
Get full text

Predictors of relapse in patients with Crohn's disease in remission after 1 year of biological therapy by Molnár, T., Lakatos, P. L., Farkas, K., Nagy, F., Szepes, Z., Miheller, P., Horváth, G., Papp, M., Palatka, K., Nyári, T., Bálint, A., Lőrinczy, K., Wittmann, T.

“…Summary Background Some of the most important questions relating to the use of biological therapy in inflammatory bowel diseases concern the duration of…”
Get full text

MLH1 and MSH2 mutation screening in HNPCC families of Hungary – Two new MMR gene mutations by Tanyi, M, Olasz, J, Tanyi, J.L, Tóth, L, Antal-Szalmás, P, Ress, Z, Bubán, T, Palatka, K, András, C, Urbancsek, H, Garami, Z, Csuka, O, Damjanovich, L

“…Abstract Introduction Hereditary Non-Polyposis Colorectal Cancer is an inherited disease with deleterious germline mutations in the DNA mismatch repair genes…”
Get full text

NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's disease by Molnar, T, Hofner, P, Nagy, F, Lakatos, P.L, Fischer, S, Lakatos, L, Kovacs, A, Altorjay, I, Papp, M, Palatka, K, Demeter, P, Tulassay, Z, Nyari, T, Miheller, P, Papp, J, Mandi, Y, Lonovics, J

“…Abstract Background NOD1/CARD4, a member of the pattern-recognition receptor family, is a perfect candidate as a susceptibility gene for Crohn's disease. Since…”
Get full text

Anti-TNF-alpha antibody (infliximab) therapy supports the recovery of eNOS and VEGFR2 protein expression in endothelial cells by Altorjay, I, Veréb, Z, Serfozo, Z, Bacskai, I, Bátori, R, Erdodi, F, Udvardy, M, Sipka, S, Lányi, Á, Rajnavölgyi, É, Palatka, K

“…The aim of this study is to investigate the effect of sera obtained from patients of Crohn's disease treated by anti-TNF-alpha antibody (Infliximab) on the…”
Get more information

183 MANNOSE-BINDING LECTIN DEFICIENCY CONFERS RISK FOR INFECTIONS IN A LARGE HUNGARIAN COHORT OF PATIENTS WITH LIVER CIRRHOSIS by Papp, M, Vitalis, Z, Tornai, I, Palatka, K, Kacska, S, Farkas, G, Udvardy, M, Harsfalvi, J, Dinya, T, Orosz, P, Lombay, B, Par, A, Par, G, Csak, T, Osztovics, J, Szalay, F, Csepregi, A, Lakatos, P.L, Altrojay, I

Get full text

079 Investigations on the frequency of chronic inflammatory intestinal disorders in patients with hidradenitis suppurativa by Palatka, R., Janka, E.A., Palatka, K., Szegedi, A., Gáspár, K.

Get full text

Investigating the biomarker role of angiotensin-converting and chitotriosidase enzymes in inflammatory diseases by Szabó, A.Á., Lóczi, L., Enyedi, E.E., Papp, M., Sipeki, N., Élthes, Z.B., Pintér, T.B., Tóth, Z.B., Palatka, K., Pályu, E., Juhász, L., Fagyas, M., Bagoly, Z.

Get full text

PGI50 - HAPPY TOMORROW BUT GLOOMING ELDERLY? SELF-ESTIMATION OF FUTURE HEALTH IN CROHN’S DISEASE by Péntek, M., Gulácsi, L., Herszényi, L., Palatka, K., Lakatos, P.L., Banai, J., Brodszky, V., Rencz, F.

Get full text

P495 Vedolizumab trough concentrations and histological remission in Ulcerative Colitis: Results from the LOVE-UC study by Hanzel, J, Baert, F, Löwenberg, M, Ferrante, M, Bossuyt, P, Hoentjen, F, Franchimont, D, Palatka, K, Peeters, H, Mookhoek, A, de Hertogh, G, Clasquin, E, Vermeire, S, D'Haens, G

“…Abstract Background To date, the association between vedolizumab (VDZ) serum concentrations and histological remission in ulcerative colitis (UC) has not been…”
Get full text

PRM185 - COMPARISON OF THE MEASUREMENT PROPERTIES OF THE EQ-5D-5L AND EQ-5D-3L IN PATIENTS WITH CROHN’S DISEASE by Rencz, F, Brodszky, V, Gulácsi, L, Palatka, K, Lakatos, PL, Herszényi, L, Banai, J, Péntek, M

Get full text

Effect of L-arginine on in vitro plasmin-generation and fibrinogenolysis by Udvardy, M, Posán, E, Palatka, K, Altorjay, I, Harsfalvi, J

“…L-arginine has received much attention in numerous aspects of the regulation of vascular tone and haemostasis. L-arginine seems to be capable to bind to…”
Get full text

P674 Blood thiopurine level, anti-TNF drug level and body composition parameters in inflammatory bowel diseases patients: a cross-sectional study in a Hungarian IBD centre by Szántó, K, Szíjártó, A L, Kata, D, Földesi, I, Mezei, Z A, Fábián, A, Bálint, A, Bor, R, Farkas, K, Milassin, Á, Rutka, M, Szepes, Z, Nagy, F, Bubán, T, Lovas, S, Palatka, K, Molnár, T

“…Abstract Background Clinical data suggest a synergistic effect between thiopurine and anti-tumour necrosis factor (anti-TNF) therapy in IBD. However,…”
Get full text

Attempted Suicide With Pilocarpine Eyedrops by Pfliegler, George P., Palatka, Károly

“…To alert ophthalmologists about the hazards of poisoning with ophthalmic solutions. We treated an 18-year-old man who attempted suicide by drinking and…”
Get full text

P580 Prognostic factors, effectiveness and safety of endoscopic balloon dilatation for de novo and anastomotic strictures in Crohn's disease – a multicenter “real life” study by Balint, A., Torocsik, D., Palatka, K., Szepes, Z., Szucs, M., Ferenci, T., Nagy, F., Farkas, K., Fábián, A., Bor, R., Milassin, A., Rutka, M., Molnar, T.

Get full text

P495 Does drug level monitoring help us to understand the mechanism behind the superiority of combo therapy in inflammatory bowel diseases? by Fábián, A, Szántó, K, Szíjártó, A L, Bor, R, Bálint, A, Farkas, K, Milassin, Á, Rutka, M, Szepes, Z, Földesi, I, Kata, D, Mezei, Z A, Lovas, S, Palatka, K, Molnár, T

“…Abstract Background Clinical data suggest a synergistic effect between thiopurine and anti-tumour necrosis factor (anti-TNF) therapy both in ulcerative colitis…”
Get full text

P410 Has body composition any effect on thiopurine level in IBD? by Milassin, Á, Szántó, K, Fábián, A, Bor, R, Farkas, K, Bálint, A, Rutka, M, Földesi, I, Szijártó, A L, Mezei, Z A, Bubán, T, Nagy, F, Szepes, Z, Molnár, T, Palatka, K

“…Abstract Background Thiopurines are the most commonly used immunosuppressive therapies in mild-to-moderate IBD. Azathioprine (AZA) is a prodrug, metabolised in…”
Get full text

P534 IBD-related malignancies observed in 2015–2018: 4 years’ results from the prospective nationwide Hungarian registry by Milassin, A, Rutka, M, Farkas, K, Bálint, A, Bor, R, Fábián, A, Szepes, Z, Szamosi, T, Szántó, K, Miheller, P, Barta, Z, Banai, J, Kovács, Á, Salamon, Á, Lakatos, L, Lakner, L, Palatka, K, Papp, M, Schafer, E, Novák, J, Erdélyi, Z, Kürti, Z, Lakatos, P L, Sarlós, P, Szigeti, N, Veres, G, Zaránd, A, Gelley, A, Vincze, Á, Nagy, F, Molnár, T

“…Abstract Background Inflammatory bowel diseases (IBD – Crohn’s disease (CD); ulcerative colitis (UC)) are associated with an increased risk of colorectal…”
Get full text

Increased in vivo platelet activation and reduced intravascular endothelium-derived relaxing factor and nitrate/nitrite production in patients with insulin-dependent diabetes mellitus by Udvardy, M., Kaplar, M., Rejto, L., Tornai, I., Palatka, K., Laszlo, P., Huszka, M.

“…Limited information seems to be available about the role of reduced endothelial production of endotheliumderived relaxing factor (EDRF)-nitrate/nitrite (NO) in…”
Get full text